NCT01709903 - A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149 | Biotech Hunter

Enrollment

744

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

QVA149

QVA149 110/50 µg capsules q.d. for inhalation, delivered via Novartis single dose dry powder inhaler (SDDPI).

DRUG

Fluticasone/salmeterol

Active fluticasone/salmeterol (500/50µg) b.i.d via a dry power inhaler Accuhaler® device.

DRUG

Placebo to QVA149

Placebo to QVA149 with SDDPI

DRUG

Placebo to fluticasone/salmeterol

Placebo to fluticasone/salmeterol with Accuhaler

Trial Locations (55)

112

Novartis Investigative Site, Taipei

1122

Novartis Investigative Site, Caba

1900

Novartis Investigative Site, La Plata

7600

Novartis Investigative Site, Mar del Plata

33305

Novartis Investigative Site, Lin-Ko

40705

Novartis Investigative Site, Taichung

81346

Novartis Investigative Site, Kaohsiung City

83301

Novartis Investigative Site, Niaosong Township

100020

Novartis Investigative Site, Beijing

100023

Novartis Investigative Site, Beijing

100029

Novartis Investigative Site, Beijing

100034

Novartis Investigative Site, Beijing

100050

Novartis Investigative Site, Beijing

100730

Novartis Investigative Site, Beijing

110016

Novartis Investigative Site, Shengyang

200032

Novartis Investigative Site, Shanghai

200080

Novartis Investigative Site, Shanghai

200433

Novartis Investigative Site, Shanghai

210029

Novartis Investigative Site, Nanjing

215004

Novartis Investigative Site, Suzhou

266011

Novartis Investigative Site, Qingdao

310003

Novartis Investigative Site, Hangzhou

310006

Novartis Investigative Site, Hangzhou

310016

Novartis Investigative Site, Hangzhou

330006

Novartis Investigative Site, Nanchang

400037

Novartis Investigative Site, Chongqing

400038

Novartis Investigative Site, Chongqing

400042

Novartis Investigative Site, Chongqing

410003

Novartis Investigative Site, Changsha

410011

Novartis Investigative Site, Changsha

430022

Novartis Investigative Site, Wuhan

530021

Novartis Investigative Site, Nanning

610041

Novartis Investigative Site, Chengdu

710032

Novartis Investigative Site, Xi’an

710061

Novartis Investigative Site, Xi’an

2520024

Novartis Investigative Site, Viña del Mar

8431633

Novartis Investigative Site, Santiago

C1125ABE

Novartis Investigative Site, Buenos Aires

B8000XAV

Novartis Investigative Site, Caba

C1056ABJ

Novartis Investigative Site, Caba

C1280AEB

Novartis Investigative Site, Caba

C1424BSF

Novartis Investigative Site, Caba

C1425BEN

Novartis Investigative Site, Caba

B2705XAE

Novartis Investigative Site, Rojas

X5016KEH

Novartis Investigative Site, Córdoba

T4000IFL

Novartis Investigative Site, San Miguel de Tucumán

Piso 1

Novartis Investigative Site, Santiago

Unknown

Novartis Investigative Site, Santiago

Novartis Investigative Site, Shenyang

Novartis Investigative Site, Beijing

Novartis Investigative Site, Jiangyin

Novartis Investigative Site, Nanjing

Novartis Investigative Site, Taipei County

050000

Novartis Investigative Site, Shijiazhuang